BackPalisade Bio Overview

Palisade Bio Current Cash

Track Palisade Bio's current cash ($130M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$132.63M
1734.41% YoYΔ $125.40M vs prior year quarter

Peer average

Loading

Palisade Bio Current Cash History

Loading

Palisade Bio vs. peers: Current Cash Comparison

Loading

Palisade Bio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Palisade Bio (PALI) FAQ

As of the most recent data (March 2026), PALI shows a current cash of $130M. That compares with $7.2M in the prior-year period — up 1734.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PALI's current cash is now $130M (was $7.2M) — a 1734.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Palisade Bio is outperforming or lagging.

Tracking PALI's current cash over time shows whether Palisade Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $130M That compares with $7.2M in the prior-year period — up 1734.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Palisade Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $130M) with ownership activity and broader fundamentals.

Palisade Bio's current cash is $130M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.